Monkeypox: The State of the Science

A public health webinar

APHA and the National Academy of Medicine hosted this free webinar on Aug. 18, 2022. A panel of experts discussed the current state of the science of monkeypox, the disease epidemiology as we understand it today, available and emergent prevention options, critical research questions we need to answer, and what we should consider and plan for as we respond to this outbreak.

Presenter slides (PDF)

Webinar transcript (PDF)



Learn about our expert speakers:

Emily Erbelding, BoghumaKabisen Titanji, David Heymann and Demetre Daskalakis

Emily Erbelding
Director, Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases

Emily Erbelding, M.D., M.P.H., serves as Director of the NIAID Division of Microbiology and Infectious Diseases (DMID). Dr. Erbelding is responsible for the strategic and scientific vision for DMID's complex national and international research program. DMID supports basic, preclinical, and clinical investigations into the causes, diagnosis, treatment, and prevention of a broad range of pathogens, including those related to biodefense and emerging infectious diseases.
Prior to joining DMID in 2017, Dr. Erbelding served as Deputy Director of the Division of AIDS at NIAID. There she was involved in all aspects of scientific program management and support, helping to design and implement new initiatives involving basic, translational and clinical research and administering complex extramural grant programs and research infrastructure. Dr. Erbelding also spent 14 years on the faculty of the Johns Hopkins University School of Medicine, in the Division of Infectious Diseases, and was the Director of Clinical Services for the Baltimore City Health Department STD/HIV program.

Boghuma Kabisen Titanji
Assistant Professor of Medicine, Division of Infectious Disease
Emory University

Boghuma Kabisen Titanji is a Cameroonian born physician-scientist and Assistant Professor of Medicine at Emory University in Atlanta. She obtained her MD from the University of Yaoundé I in Cameroon where she worked as a medical officer after graduating, before pursuing postgraduate research training in the United Kingdom. She obtained a Masters Degree in Tropical Medicine and International Health from the London School of Hygiene and Tropical Medicine, a diploma in Tropical Medicine and Hygiene from the Royal College of Physicians in London and a PhD in Virology from University College London. She joined Emory University School of Medicine in 2016 where she completed a residency in Internal Medicine, and a fellowship in Infectious Diseases. She has three parallel career interests: translational and clinical research in HIV and emerging viruses, science communication, and global health equity. Her clinical focus is general infectious diseases and people with HIV.

David Heymann
Professor of Infectious Disease Epidemiology
London School of Hygiene & Tropical Medicine

David Heymann is a medical epidemiologist and Professor of Infectious Disease Epidemiology at LSHTM. From 2009 to 2017 he was chairman of Public Heath England and Head of the Centre on Health Security at Chatham House (London). From 1989 to 2009 he held various leadership positions in infectious diseases at WHO, and in 2003 headed the WHO global response to SARS in his role as executive director of communicable diseases. In 1976, after spending two years working in India on smallpox eradication, Heymann was a member of the CDC (Atlanta) team to investigate the first Ebola outbreak in DRC and stayed on in sub-Saharan Africa for 13 years in various CCD field research positions on Ebola, monkeypox, Lassa Fever, malaria and other tropical diseases. Heymann has published over 250 peer reviewed articles and book chapters, is editor of the Control of Communicable Diseases Manual, and is an elected member of the UK Academy of Medical Sciences and the US National Academy of Medicine. In 2009 he was named an Honorary Commander of the Most Excellent Order of the British Empire for services to global health.

Demetre Daskalakis
White House National Monkeypox Response Deputy Coordinator
Dr. Demetre Daskalakis serves as Director of the Division of HIV Prevention at the Centers for Disease Control, where he oversees HIV prevention efforts. Dr. Daskalakis worked in the CDC COVID-19 response as a lead in health equity as well as the head of the vaccine task force. Prior to joining the CDC, Dr. Daskalakis served as New York City Department of Health’s Deputy Commissioner for the Division of Disease Control. In that role, Dr. Daskalakis oversaw many of New York City’s HIV and STD education and response programs, which helped drive HIV incidence to an historic low and also served as Incident Commander during the COVID-19 and Measles outbreaks. He has authored over 60 scholarly articles and has been widely recognized for his expertise and advocacy for the health issues affecting the LGBTQIA+ communities.